Tirzepatide

Tirzepatide is a dual-action peptide that mimics the effects of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), hormones naturally released after a meal to promote insulin secretion. Known for its effectiveness in managing type 2 diabetes and obesity, Tirzepatide significantly improves glycemic control and promotes weight loss by enhancing insulin sensitivity and reducing appetite. Additionally, it offers cardiovascular benefits by lowering blood pressure and reducing lipid levels, which may decrease the risk of cardiovascular events such as heart attacks and strokes in individuals with type 2 diabetes. Tirzepatide also supports improved metabolic health, making it a comprehensive therapy for metabolic disorders.